{"name":"PepGen Inc","slug":"pepgen-inc","ticker":"","exchange":"","domain":"pepgen.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"PGN-EDODM1 for infusion","genericName":"PGN-EDODM1 for infusion","slug":"pgn-edodm1-for-infusion","indication":"Other","status":"phase_1"},{"name":"PGN-EDODM1","genericName":"PGN-EDODM1","slug":"pgn-edodm1","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"PGN-EDODM1 for infusion","genericName":"PGN-EDODM1 for infusion","slug":"pgn-edodm1-for-infusion","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"PGN-EDODM1","genericName":"PGN-EDODM1","slug":"pgn-edodm1","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxORHVleGc4Rzl1NEJnU3N0c2Y4ME9Ea0djNFlPWXZrWGJIMEk0Q1pRUE9YYUVMbWdHWEdla21TdmRSSXlHbGJuem5wX2QxUG82bS1Bd1pkM29ZaEZRUEYtMHhsV2tsd0s3eElNazlkdDNYU3hQRmpvRUJycGxhNEZnSmItaXpWMDh2eGxoZ0VDV1BQRHpZNy1oNHh3M1FUOWx5VERKUDZwZk5lUkhPaFlLWFI2Z3hWTjJqX3dZdkVWbWt6YmFzZ2JsYm5HOA?oc=5","date":"2026-04-02","type":"pipeline","source":"Sahm","summary":"Scholar Rock To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday - Sahm","headline":"Scholar Rock To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNVjZCcHluOXN2MW8xZ2hWQzJldnZJcjE1RWVHVm4xS1RTN2lMWDAyNGZjNVlRM2RFeU00X2RUaGNlV1lqSXpMRC1SS0NaV04xM0MtWG1keG5qSzhlcjVmMDRKLV9sN2prYzE0VHZOUmJlRzJMeWNjenhyQ093cC00OHlDUkVEbUJnWFZoZThJZTdsdGlHbVBzNC1iVQ?oc=5","date":"2026-03-31","type":"trial","source":"openPR.com","summary":"Myotonic Dystrophy (DM) Clinical Trial Pipeline Expands as 20+ - openPR.com","headline":"Myotonic Dystrophy (DM) Clinical Trial Pipeline Expands as 20+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOZEtKemFsQmd3eEd6aVJtN0lwbVN1YWttR2VxenE0YzlTX0NtVk1tM3MxeGRCX09ralhndzhEUHQ2dlpxMUtlem5lRjhzeDM5NkRQZzU2Z09UbzBjWVl2aXJpckRkZmxyOXhqbGhUbjNkdDRUMEpOSTNMV1VzODZfTXQwbnByQlBFV3RYaHV0b28xNm15bDdpSVE4YkRDUUl2MEh0SjNfdENHbzAydDlGMzVyU2dOZw?oc=5","date":"2026-03-31","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga","headline":"12 Health Care Stocks Moving In Tuesday's Pre-Market Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9TZUpZckdnUHJ3SlhPRUhvUFRPOUZ3cWlIMmUtQ2FYdTg3aDNaaVZVSllvS0hOR1NTUEUyeHlWTDA1dTY2akRseFFNTTY3ZnFnSmlHTmRETVFnZGx1bklvYmI0QXF3T19pZDVCLTNB?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in PepGen Inc (PEPG) - Stock Titan","headline":"If You Invested $1,000 in PepGen Inc (PEPG)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQQnducXhNc2tlMUU5OWxPdzFyOGVfa1J3SlVlS2lVM0JMbGlPTmdRZmRRLU5ZVU5adklZMjkyYU9NWkVOSUZhZ0NTQW5Hay1fbnpiRkF1OE9rZW5wYTF1SU5zMmMyOVp4akc2V1FlOTQ0aHJuSDhyM19OMWhDeDRzMDFsdS10WlJXSjlWME1QTXpxLVhlTWFaNXJpQTlKWktBR0VIWk5veWNFc3JSY0huTEhBeHZ6cFFSb09zNnlDYTlUVDZya1NfeXFyVmJKN0xtYnptalcyXzIyQQ?oc=5","date":"2026-03-06","type":"deal","source":"The Globe and Mail","summary":"Oppenheimer Sticks to Their Buy Rating for PepGen Inc. (PEPG) - The Globe and Mail","headline":"Oppenheimer Sticks to Their Buy Rating for PepGen Inc. (PEPG)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPc0lSYTBvbW9OSmd1XzRJM3Qxbks5X1dEZHM0TjZxUnFtcnI5T2ZzUDQtRjNrOU92cTh6OEZTZ1ZZdTJQbHFFUmU1bnpVTGllMVRITnUwcTlpdUNBZk9jVHp2LWdnWFV2M09Rd0gxS1hyWEQxeE9KeHVKOEtEX00wemN6bWZ3cWlaZFhZaG5ZS2t2UQ?oc=5","date":"2026-03-05","type":"regulatory","source":"BioPharma Dive","summary":"PepGen muscular dystrophy drug gets ‘surprise’ hold from FDA - BioPharma Dive","headline":"PepGen muscular dystrophy drug gets ‘surprise’ hold from FDA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOQlZZNTk2U09lMzZSN2hiOHFZRFNJQXdRZENjMHBYMHdJTktQRGdOMEhfYXFoOUljQk5rTDF4NzhWYndWY3FMYTZJZXR1VlpEZmZoVllqb205ck1zOWR5Rm1zUlEtZzFyWDYwRGlkTjhPd3Z1QnRKeldkVlZmcTZGZGdHR3ZVcmpnZzE0NnhwYUozSzBSeU9VTWxDbGNjMzlEb2c3X256SWs?oc=5","date":"2026-03-05","type":"regulatory","source":"seekingalpha.com","summary":"PepGen: Stock Slides On FDA Study Hold - I'm Firmly On The Sidelines (NASDAQ:PEPG) - seekingalpha.com","headline":"PepGen: Stock Slides On FDA Study Hold - I'm Firmly On The Sidelines (NASDAQ:PEPG)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFBvekpoSTcxNThhbEZRNEpNaEZDbWphelNPeDVNU3p1aVhLUXFyWWxOYXpiV0ZlUlpONWtVQUJISWUybDhBMUhGbmdwQjFiTVlId0lnZ1ozbXJ2OVdseGV4SWRlWTJ0X0xXYUF6d3Q0d29JRVVuOVhibA?oc=5","date":"2026-03-05","type":"regulatory","source":"pharmaphorum","summary":"PepGen slumps as FDA places hold on lead drug - pharmaphorum","headline":"PepGen slumps as FDA places hold on lead drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNTzVSR0UwcEpUUUxoVlJOOWVBdzZzSjN1cWctQTl4bnpZSkZsRnBYSS1iS19MNDZnbHpBMUs1UWJmdFNjMUxrT2Z0Nko4ZkstQndDdEwxU3RuUFhFQVdyM3doVG9GU3k2eWxrOTlWUWlfQlRDNkdiUUtMdTVvTmhDZVJ3bFZ1Znp0dVkxQWFudTBNbzFGWUNNMnc1UjNjRGtRTVUxVVVaZ3duWVZYSWpoMUh3OTlEek1hSTNLc245aG45Y3F3MGVaZERKeW90MnVHMHhZaHNR?oc=5","date":"2026-03-04","type":"regulatory","source":"Reuters","summary":"US FDA puts partial clinical hold on PepGen's muscle disease drug trial - Reuters","headline":"US FDA puts partial clinical hold on PepGen's muscle disease drug trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNQ29zbURRZmpZV1JvaElxdTNNNTU1bGotaUlhaDBNbWdEWTBFbzhKaUF4ellSSGJrblBycTd3ek9GQUlUMmptMTBLZ29oM19VU3ZQckM3WjlGaXBZMnRNT3pMRGRaZWVZaklhV2lURE9Bd3lZLVdPeFIwT2laTDFtU0hrWDZ3aHBSRGlubA?oc=5","date":"2025-10-07","type":"pipeline","source":"seekingalpha.com","summary":"PepGen: DMD Discontinued, Ways To Go With DM1 (NASDAQ:PEPG) - seekingalpha.com","headline":"PepGen: DMD Discontinued, Ways To Go With DM1 (NASDAQ:PEPG)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQWW5NT3ZQNURGZDhMWnZVakdRWTZONVhxRWNvSEZlTkFzcERtdmJVVGhnVms1Y1l5NTBKdlEtdmNhMUtGemZ5Yjlwc2pPT1ppTXNNUlpqeDVZV1JkSXE1eXZCVlJEX2pIRVZUOUFOOU02N05XcERuYzJaeGV5U19tNmNLVHBTMFBvamRjcg?oc=5","date":"2025-09-24","type":"pipeline","source":"Yahoo Finance","summary":"PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients - Yahoo Finance","headline":"PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNV2FrUDlvVVJJbU1BTTZuTWFoVUJMX3ZIRUJQSU5RTWpfdG5YcklnNEtOdHZ1VkRLMkxwQkQ1eDlqNUgzN2EtRldjOUdiQXVfcUNBZElWbU9hNlFRUW5XcFVSaEhxbTQ4VzJYdkprOU9pRVhLNmJnemlDRlYtUlRVUWdiNG9IdWVPLTk1LVB5bWNMODR3V3pZ?oc=5","date":"2025-06-05","type":"pipeline","source":"The Business Journals","summary":"Petri Dish: PepGen halts work on Duchenne drug; Needham biotech announces layoffs - The Business Journals","headline":"Petri Dish: PepGen halts work on Duchenne drug; Needham biotech announces layoffs","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_2":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}